αB-crystallin and HSP27 in glial cells in tauopathies

Neuropathology

Volumn 34, Issue 6, 2014, Pages 517-526

  López González, Irene ^a   Carmona, Margarita ^a   Arregui, Laura ^a   Kovacs, Gabor G ^b   Ferrer, Isidre ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Astrocytes; HSP27; Oligodendrocytes; Tauopathies; B crystallin

Indexed keywords

ALPHA CRYSTALLIN; HEAT SHOCK PROTEIN 27; TAU PROTEIN; HSPB1 PROTEIN, HUMAN;

ALZHEIMER DISEASE; ARGYROPHILIC GRAIN DISEASE; ARTICLE; CELL SUBPOPULATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GLIA CELL; NEUROLOGIC DISEASE; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TAU GENE; TAUOPATHY; BRAIN; GLIA; HUMAN; METABOLISM; NERVE CELL; PHOSPHORYLATION;

ALPHA-CRYSTALLIN B CHAIN; BRAIN; HSP27 HEAT-SHOCK PROTEINS; HUMANS; NEUROGLIA; NEURONS; PHOSPHORYLATION; TAU PROTEINS; TAUOPATHIES;

EID: 84915767682     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/neup.12134     Document Type: Article

References (59)

1. Buée Scherrer V, Hof PR, Buée L etal. Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease. Acta Neuropathol 1996; 91: 351-359.
2. Buée L, Delacourte A. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease. Brain Pathol 1999; 9: 681-693.
3. Togo T, Sahara N, Yen SH etal. Argyrophilic grain disease is a sporadic 4-repeat tauopathy. J Neuropathol Exp Neurol 2002; 61: 547-556.
4. Tolnay M, Sergeant N, Ghestem A etal. Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms. Acta Neuropathol 2002; 104: 425-434.
5. Dickson DW, Ahmed Z, Algom AA, Tsuboi Y, Josephs KA. Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol 2010; 23: 394-400.
6. Kouri N, Whitwell JL, Josephs KA, Rademakers R, Dickson DW. Corticobasal degeneration: a pathologically distinct 4R tauopathy. Nat Rev Neurol 2011; 7: 263-372.
7. Ghetti B, Hutton ML, Wszolek ZK. Frontotemporal dementia and parkinsonism linked to chromosome 17 associated with tau gene mutations (FTDP-17). In: Dickson D, ed. Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. Basel: ISN Neuropathol Press, 2003; 86-102.
8. Hogg M, Grujic ZM, Baker M etal. The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy. Acta Neuropathol 2003; 106: 323-336.
9. Muñoz DG, Ferrer I. Neuropathology of hereditary forms of frontotemporal dementia and parkinsonism. In: Duyckaerts C, Litvan I, eds. Handbook of Clinical Neurology: Dementias. Edinburgh, London, New York, Oxford, Philadelphia, St. Louis, Sydney, Toronto: Elsevier, 2008; 393-414.
10. Goedert M, Spillantini MG. Pathogenesis of the tauopathies. J Mol Neurosci 2011; 45: 425-431.
11. Dickson DW, Kouri N, Murray ME, Josephs KA. Neuropathology of frontotemporal lobar degeneration-tau (FTLD-Tau). J Mol Neurosci 2011; 45: 384-389.
12. Togo T, Dickson DW. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process. Acta Neuropathol 2002; 104: 398-402.
13. Ferrer I, Santpere G, van Leeuwen FW. Argyrophilic grain disease. Brain 2008; 146: 1640-1651.
14. Iwasaki Y, Yoshida M, Hattori M etal. Distribution of tuft-shaped astrocytes in the cerebral cortex in progressive supranuclear palsy. Acta Neuropathol 2004; 108: 399-405.
15. Takeda N, Kishimoto Y, Yokota O. Pick's disease. Adv Exp Med Biol 2012; 724: 300-316.
16. Arima K, Nakamura M, Sunohara N etal. Ultrastructural characterization of the tau-immunoreactive tubules in the oligodendroglial perikarya and their inner loop processes in progressive supranuclear palsy. Acta Neuropathol 1997; 93: 558-566.
17. Arima K. Ultrastructural characteristics of tau filaments in tauopathies: immuno-electron microscopic demonstration of tau filaments in tauopathies. Neuropathology 2006; 26: 475-483.
18. Spillantini MG, Goedert M, Crowther RA, Murrell JR, Farlow MR, Ghetti B. Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments. Proc Natl Acad Sci USA 1997; 94: 4113-4118.
19. Bird TD, Nochlin D, Poorkaj P etal. A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L). Brain 1999; 122: 741-756.
20. Spina S, Farlow MR, Unverzagt FW etal. The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family. Brain 2008; 131: 72-89.
21. Zarranz JJ, Ferrer I, Lezcano E etal. A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease. Neurology 2005; 64: 1578-1585.
22. Bigio EH, Lipton AM, Yen SH etal. Frontal lobe dementia with novel tauopathy: sporadic multiple system tauopathy with dementia. J Neuropathol Exp Neurol 2001; 60: 328-341.
23. Ahmed Z, Doherty KM, Silveira-Moriyama L etal. Globular glial tauopathies (GGT) presenting with motor neuron disease or frontotemporal dementia: an emerging group of 4-repeat tauopathies. Acta Neuropathol 2011; 122: 415-428.
24. Kovacs GG, Majtenyi K, Spina S etal. White matter tauopathy with globular glial inclusions: a distinct sporadic frontotemporal lobar degeneration. J Neuropathol Exp Neurol 2011; 67: 963-975.
25. Kovacs GG, Molnár K, Lászlo L etal. A peculiar constellation of tau pathology defines a subset of dementia in the elderly. Acta Neuropathol 2011; 122: 205-222.
26. Dabir DV, Trojanowski JQ, Richter-Landsberg C etal. Expression of the small heat shock protein αB-crystallin in tauopathies with glial pathology. Am J Pathol 2004; 164: 155-166.
27. Schwarz L, Vollmer G, Richter-Landsberg C. The small heat shock protein HSP25/27 (HspB1) is abundant in cultured astrocytes and associated with astrocytic pathology in progressive supranuclear palsy and corticobasal degeneration. Int J Cell Biol 2010; 2010: 717520.
28. Haley DA, Horwitz J, Stewart PL. The small heat shock protein, αB-crystallin, has a variable quaternary structure. J Mol Biol 1998; 277: 27-35.
29. Mounier N, Arrigo AP. Actin cytoskeleton and small heat shock proteins: how do they interact? Cell Stress Chaperones 2002; 7: 167-176.
30. Pivovarova AV, Mikkhailova DI, Chernik IS, Chebotareva NA, Levitsky DI, Gusev NB. Effects of small heat shock proteins on the thermal denaturation and aggregation of F-actin. Biochem Biophys Res Commun 2005; 331: 1548-1553.
31. Nichol ID, Quinlan RA. Chaperone activity of crystallins modulates intermediate filament assembly. EMBO J 1994; 13: 945-953.
32. Lindquist S, Craig EA. The heat-shock proteins. Annu Rev Genet 1998; 22: 631-677.
33. Haslbeck M, Fanzmann T, Weintfurtner D, Buchner J. Some like it hot: the structure and function of small heat-shock proteins. Nat Struct Mol Biol 2005; 12: 842-846.
34. Ferrer I, Martinez A, Boluda S, Parchi P, Barrachina M. Brain banks: benefits, limitations and cautions concerning the use of post-mortem brain tissue for molecular studies. Cell Tissue Bank 2008; 9: 181-194.
35. Iwaki T, Wisniewski T, Iwaki A etal. Accumulation of αB-crystallin in central nervous system glia and neurons in pathologic conditions. Am J Pathol 1992; 140: 345-356.
36. Wilhelmus MM, Otte-Höller I, Wesseling P, de Waal RM, Boelens WC, Verbeek MM. Specific association of small heat shock proteins with the pathological hallmarks of Alzheimer's disease brains. Neuropathol Appl Neurobiol 2006; 32: 119-130.
37. Kannan R, Sreekumar PG, Hinton DR. Novel roles for α-crystallins in retinal function and disease. Prog Retin Eye Res 2012; 31: 576-604.
38. Dou G, Sreekumar PG, Spee C etal. Deficiency of αB-crystallin augments ER stress-induced apoptosis by enhancing mitochondrial dysfunction. Free Radic Biol Med 2012; 53: 1111-1122.
39. Ilieva EV, Naudí A, Kichev A, Ferrer I, Pamplona R, Portero-Otín M. Depletion of oxidative and endoplasmic reticulum stress regulators in Pick disease. Free Radic Biol Med 2010; 48: 1302-1310.
40. Ilieva EV, Kichev A, Naudí A, Ferrer I, Pamplona R, Portero-Otín M. Mitochondrial dysfunction, and oxidative and endoplasmic reticulum stress in argyrophilic grain disease. J Neuropathol Exp Neurol 2011; 70: 253-263.
41. Doyle KM, Kennedy D, Gorman AM, Gupta S, Healy SJ, Samali A. Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders. J Cell Mol Med 2011; 15: 2025-2039.
42. Nijholt DA, van Haastert ES, Rozemuller AJ, Scheper W, Hoozemans JJ. The unfolded protein response is associated with early tau pathology in the hippocampus of tauopathies. J Pathol 2012; 226: 693-702.
43. Head MW, Goldman JE. Small heat shock proteins, the cytoskeleton, and inclusion body formation. Neuropathol Appl Neurobiol 2000; 26: 304-312.
44. Richter-Landsberg C, Bauer NG. Tau-inclusion body formation in oligodendroglia: the role of stress proteins and protreasome inhibition. Int J Dev Neurosci 2004; 22: 443-451.
45. Zantema A, Verlaan-De Vries M, Maasdam D, Bol S, van der Eb A. Heat shock protein 27 and lpha B-crystallin can form a complex, which dissociates by heat shock. J Biol Chem 1992; 267: 12936-12941.
46. Liu C, Welsh MJ. Identification of a site of Hsp27 binding with Hsp27 and alpha B-crystallin as indicated by the yeast two-hybrid system. Biochem Biophys Res Commun 1999; 255: 256-261.
47. Fu L, Liang JJ. Enhanced stability of alpha B-crystallin in the presence of small heat shock protein Hsp27. Biochem Biophys Res Commun 2003; 302: 710-714.
48. Mehlen P, Arrigo AP. The serum-induced phosphorylation of mammalian hsp27 correlates with changes in its intracellular localization and levels of oligomerization. Eur J Biochem 1994; 221: 327-334.
49. Ito H, Kamei K, Iwamoto I, Inaguma Y, Nohara D, Kato K. Phosphorylation-induced change of the oligomerization state of αB-crystallin. J Biol Chem 2001; 276: 5346-5352.
50. Aquilina JA, Benesch LL, Ding O, Yaron J, Horwitz CV, Robinson J. Phosphorylation of αB-crystallin alters chaperone function through loss of dimeric substructure. J Biol Chem 2004; 279: 28675-28680.
51. Ito H, Okamoto K, Nakayama H, Isobe T, Kato K. Phosphorylation of αB-crystallin in response to various types of stress. J Biol Chem 1997; 272: 29934-29941.
52. Martínez A, Portero-Otin M, Pamplona R, Ferrer I. Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates. Brain Pathol 2010; 20: 281-297.
53. Muntané G, Dalfó E, Martínez A etal. Glial fibrillary acidic protein is a major target of glycoxidative and lipoxidative damage in Pick's disease. J Neurochem 2006; 99: 177-185.
54. Santpere G, Ferrer I. Delineation of early changes in cases with progressive supranuclear palsy-like pathology. Astrocytes in striatum are primary targets of tau phosphorylation and GFAP oxidation. Brain Pathol 2009; 19: 177-187.
55. Golenhofen N, Htun P, Ness W, Koob R, Schapeer W, Drenckhahn D. Binding of the stress protein αB-crystallin to cardiac myofibrils correlates with the degree of myocardial damage during ischemia/reperfusion in vivo. J Mol Cell Cardiol 1999; 31: 569-580.
56. Morrison LE, Hoover HE, Thuereauf DJ, Glembotski CC. Mimicking phosphorylation of αB-crystallin on serine-59 is necessary and sufficient to provide maximal protection of cardiac myocytes from apoptosis. Circ Res 2003; 92: 203-211.
57. Gusev NB, Bogatcheva NV, Marston SB. Structure and properties of small heat shock proteins (sHsp) and their interaction with cytoskeleton proteins. Biochemistry 2006; 67: 511-519.
58. Richter-Landsberg C, Goldbaum O. Small heat shock proteins and the cytoskeleton: their role in inclusion body formation in glial cells. In: Richter-Landsberg C, ed. Heat Shock Proteins in Neural Cells. New York: Landes Bioscience-Springer, 2007; 13-24.
59. Wyttenbach A, Hands S, O'Connor V. Small stress proteins in the central nervous system: from neurodegeneration to neuroprotection. In: Simon S, Arrigo PA, eds. Small Stress Proteins in Human Diseases. New York: Nova Sci Publish, 2010; 117-146.